A new national declaration headed by ANH-USA calls for rethinking how we prevent and treat chronic illness that affects 3 in every 4 US adults. Add your name to support reform. Take Action – Co-Sign the Declaration Now! Listen to the audio version of this article: THE TOPLINE On February 10–11, 2026, we convened a summit comprised of healthcare, legal, scientific, and policy leaders in Scottsdale, Arizona, which culminated in the drafting of a declaration calling for structural reform of how America addresses chronic disease that is at risk of crippling society and breaking health systems. The Arizona Statement outlines legal, regulatory, and economic barriers that can limit access to preventive and non-pharmaceutical approaches—and proposes a path forward. This is a growing national effort that was among RJK Jr.’s key priorities when appointed HHS Secretary. He can’t do it alone. Add your name to help demonstrate public support for change. The Arizona Statement has been released today! >>> Read Press Release The United States spends more on healthcare per capita than any country in the world—yet continues to struggle with high rates of chronic disease. Conditions like diabetes, heart disease, and obesity now affect a majority of American adults. At the same time, many researchers and public health experts agree that a significant share of this burden is linked to diet, lifestyle, and other modifiable factors. So why does prevention so often take a back seat? The answer is complex. But many clinicians, researchers, and policy experts point to a common theme: the way our healthcare system is structured can make it harder to prioritize prevention and early intervention. Natural and preventive approaches to health are at the margins of healthcare through the deliberate structure of legal definitions, regulatory enforcement, and professional gatekeeping that has been constructed—and defended—over decades. That’s the challenge at the heart of the Arizona Statement on Reversing America’s Chronic Disease Epidemic, developed by ANH-USA with the help of a cross-disciplinary group of experts who met in February 2026 and have collaborated since. Now, we’re asking grassroots activists to help build momentum behind these ideas. While an Executive Order established the Make America Health Again (MAHA) Commission in February 2025 and a 120-initiative strategy was launched in September 2025, to date the focus has been primarily on children’s health; the structural problems that impact informed choice and health freedom relevant to America’s 277 million adults has largely been avoided. Not only that, the chronic disease epidemic cannot be fixed by top-down government policy alone. It requires all layers of society to be involved and the removal of structural barriers that have accumulated over decades that work to protect Big Pharma and Big Food—with US citizens paying the price both in health and economic terms. What the Arizona Statement Argues The Statement does not reject modern medicine or the role of pharmaceuticals. Instead, it argues that the current system often underutilizes lower-cost, lower-risk approaches—including nutrition, lifestyle interventions, sanitation, and natural products—due to a combination of regulatory constraints and economic incentives. Among the issues it raises: Individual liberty and informed choice. Every person has the right to receive truthful information about nutrition, lifestyle, and lawful health options—and to choose among them on the basis of fully informed consent. That right is currently being violated by a regulatory regime that decides what you’re allowed to know and what medicines you can access. Modern, science-based definitions. The legal definitions of “food” and “drug” that govern what can be said and sold in the American marketplace were not written with 21st-century nutritional science in mind. The Statement calls for modernizing these definitions so that foods, botanicals, and dietary ingredients with demonstrated therapeutic effects can be researched, discussed, and recommended without being classified as unapproved drugs. Prevention, root-cause care. America’s great gains in life expectancy over the 20th century were built on sanitation, nutrition, hygiene, and public health — not on pharmaceuticals. The Statement calls for restoring prevention and root-cause medicine to their rightful place at the center of health policy. Barriers to access and reimbursement. Many preventive or root-cause approaches are not covered by insurance programs, making them less accessible—even when they may reduce long-term health costs. These ideas are not about replacing conventional medicine, but about broadening the toolkit available to patients and practitioners. Why This Matters in Practice For many Americans, this debate is not abstract. It can mean the difference between having insurance cover a medication that brings side effects, but not a safer nutrition-based intervention. It’s the difference between treating symptoms rather than the underlying or root causes. It’s about having the right to be informed about, and to choose, non-drug approaches to health. The Arizona Statement argues that a more balanced system could improve outcomes, expand choice, and reduce long-term costs. A Growing Coalition—And a Chance to Add Your Voice The Statement has already been signed by a number of clinicians, researchers, attorneys, nonprofit leaders, and health advocates. The goal now is to demonstrate that these concerns extend beyond professional circles. Your signature helps show policymakers, regulators, and the media that there is broader public support for rethinking how we approach chronic disease. This list of signatories will support ongoing legal, regulatory, and legislative efforts aimed at expanding access to preventive and integrative approaches. Add Your Name to the Arizona Statement… If you believe prevention should play a larger role in healthcare… If you support greater access to information and a wider range of options… If you think the system can do more to address the root causes of chronic disease… Add your name to the Arizona Statement TODAY. Once you’ve done this – please forward this email or share the URL arizonastatement.org. Help build the momentum for a more balanced, prevention-focused approach to health. You can also find out more by tuning in to the Robert Scott Bell Show today at 3 pm ET (noon PT) and listen to our General Counsel Jonathan Emord and Executive & Scientific Director Rob Verkerk, the key authors of the Arizona Statement. The post Sign the Arizona Statement: Join the Bottom-Up Movement to Reverse Chronic Disease first appeared on Alliance for Natural Health USA - Protecting Natural Health.

Patients relying on natural thyroid therapies face renewed uncertainty as agency doubles down on its impending ban. Action Alert! THE TOPLINE The FDA’s March announcement makes clear that natural desiccated thyroid (NDT) is not eligible for compounding, escalating the threat to patient access. The agency plans to issue formal compliance guidance by August 2026, giving a clearer timeline for enforcement. The FDA’s reasoning is scientifically and legally inconsistent, and is advancing a strategy to protect access through regulatory, legal, and legislative pathways. In a late-March statement, the FDA doubled down on its plans to restrict access to natural thyroid treatments. This includes commercial products like Armour Thyroid as well as compounded NDT medicines. The move is a blatant betrayal of the Make America Healthy Again (MAHA) movement that will leave millions of patients who rely on NDT in the lurch. The FDA’s position is that NDT products are biologics, not drugs, under the Public Health Service Act, and thus require an approved Biologics License Application (BLA); no commercial NDT products are currently marketed under an approved BLA. By law, biologics cannot be compounded by traditional compounding pharmacies. The FDA has indicated it intends to issue formal compliance guidance by August 2026. We must band together to protect patient access to compounded NDT. A Direct Threat to Compounded Care As we noted last year, FDA Commissioner Makary provided positive signals for FDA approval of a commercial NDT product, pending clinical trial results. But even if some commercial NDT products eventually win FDA approval, compounded thyroid therapies are still on the chopping block. For many patients, compounded NDT is essential. Thyroid disorders are highly individualized, and patients often require customized dosing, specific T3/T4 ratios, and/or alternative delivery forms. These needs cannot be met by one-size-fits-all, mass-produced drugs—should they ever get approved. If the FDA’s position stands, practitioners will lose the ability to tailor care, and patients who do not respond well to synthetic drugs will be left without viable options. FDA’s Biologics Argument—And a Key Inconsistency The FDA’s classification of NDT as a biologic rests in part on the presence of thyroglobulin, a protein found in animal thyroid tissue used to make NDT. But this argument raises serious questions. In desiccated thyroid products, thyroglobulin is an inactive component. The primary therapeutic agents, typically standardized in specific ratios, are actually the thyroid hormones thyroxine (T4) and tri-iodothyronine (T3). Natural porcine or bovine NDT typically also contain small amounts of monoiodothyronine (T1), diiodothyronine (T2) and traces of reverse T3. The FDA’s own guidance has previously acknowledged that a product containing a protein only as an inactive ingredient is not considered a “protein” for purposes of biologic classification. By asserting that the mere presence of thyroglobulin makes NDT a biologic, the agency is departing from its own precedent. These and other arguments were raised in a Citizen Petition filed by the Alliance for Pharmacy Compounding, a trade group for compounding pharmacists. ANH-USA’s Strategy In response to this dire threat to patient autonomy, ANH-USA has developed a comprehensive advocacy strategy outlined in a position paper we released in September 2025. The basic contours of the plan are as follows: Short-term: Press the FDA and HHS to reclassify NDT as a drug, restoring legal pathways for compounding. Medium-term: Secure enforcement discretion for high-quality, GMP-manufactured NDT products. Long-term: Advance federal legislation creating a durable carveout to protect both compounded and commercial thyroid therapies. We believe this plan provides the best chance to retain access to compounded NDT. The Bigger Picture The threat to compounded thyroid treatments is part and parcel of a broader regulatory trend in which the FDA increasingly applies drug (or biologic) frameworks to natural and individualized therapies, regardless of their long history of safe use. The result is a system that limits physician flexibility, reduces patient choice, and favors standardized, patentable products. For patients with individualized needs, these constraints can have real and lasting health consequences. What Comes Next With formal FDA guidance expected by August 2026, the window to influence policy is narrowing. With your help, ANH-USA will continue to apply grassroots pressure on decision-makers to make compounded NDT available to patients. Action Alert! The post FDA’s Anti-MAHA Stance on Natural Thyroid first appeared on Alliance for Natural Health USA - Protecting Natural Health.

Health Secretary Robert F. Kennedy Jr. announced that he is launching a new podcast called “The Secretary Kennedy Podcast,” which focuses on “telling the truth” about health. Despite Americans being told to “trust the system,” Kennedy said the nation’s “children are sicker, chronic disease is exploding, and the answers that we’ve been given aren’t working. Many of us have come to the conclusion that government actually lies to us.” “This podcast is about telling the truth, especially when it’s uncomfortable,” he added. Kennedy is set to have “fearless conversations” with “critical thinkers,” including doctors, scientists, and leaders in medical innovation. Kennedy’s podcast further seeks to expose the hypocrisy and the conflicts and the corruption.” “We’re going to name the names of the forces that obstruct the paths to public health. This isn’t going to be about politics,” he continued. “It’s about our families, it’s about our children, and it’s about confronting the spiritual malaise and embracing the truth.” A nation can only be healthy after addressing the lies making its people spiritually, morally and physically sick, Kennedy stated. Tyler Burger, HHS digital communications manager and the podcast’s producer, told the Associated Press, “We’re kind of bringing podcasting into the government as an official form and arm of our messaging.” “Americans are united on the need to urgently address chronic disease, improve nutrition, strengthen food quality, and lower health costs,” HHS spokesman Andrew Nixon similarly noted. “The Secretary Kennedy Podcast will cover all those issues.” The podcast builds upon Kennedy’s pledge to be transparent with Americans’ health. Coming soon—The Secretary Kennedy Podcast. pic.twitter.com/CMkOmh8sFO— Secretary Kennedy (@SecKennedy) April 8, 2026 The post Kennedy to Launch Podcast appeared first on American Faith.